Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping review

Abstract

IntroductionFor patients with cancer, immune checkpoint inhibitors (ICIs) produce superior long-term responses compared with alternative treatments, although at the cost of manifesting adverse immune-related events. There are many hypotheses of the impacts of physical activities in immunotherapy, but little is known about the oncological outcomes and the underlying mechanisms. This scoping review aims to identify possible physical activity interventions, their efficacy and feasibility and the potential underlying biological mechanisms responsible for their effects.Method and analysisThe Levac methodology framework was used along with guidance from the Joanna Briggs Institute Manual for Evidence Synthesis to inform development of this protocol. Abstracts and titles followed by full-text screening will be performed by two independent reviewers for inclusion. All studies describing the impact of physical activities and exercise interventions on cancer ICIs, with particular focus on oncological outcomes, quality of life or underling biological mechanisms, will be included. After extracting qualitative and quantitative data, they will be evaluated and summarised, respectively. Subsequently, a further consultation step with other scientists and healthcare professionals will be performed.Ethics and disseminationThe research findings will be published through an open-access peer-reviewed journal. The results of this scoping review will be used to inform further studies on physical impacts on immunotherapy. All data included will be from open resources, therefore, no ethical clearances are required.

Is There a Role for Exercise When Treating Patients with Cancer with Immune Checkpoint Inhibitors? A Scoping Review

“…We followed the protocol for this scoping review which has been published before [ 27 ]. Its development was guided by the Joanna Briggs Institute Manual for Evidence Synthesis [ 28 ] and the methodology framework for scoping reviews proposed by Levac et al [ 29 ].…”

“… Flowchart of the protocol for this scoping review. Adapted using information from the published protocol [ 27 ]. [ICIs, immune checkpoint inhibitors; PPI, patient and public involvement; QoL, quality of life].…”